China-based cardiovascular healthcare provider DeltaHealth secured $100m on Friday in a funding round led by conglomerate Swire Pacific, which has become the company’s second largest shareholder.
The round also featured Eight Roads, a venture capital subsidiary of investment and financial services group Fidelity International that was described as an existing investor.
DeltaHealth operates a network of cardiovascular care facilities around China. It opened its first outpatient clinic in 2013 followed by its first hospital in Shanghai in 2016, the latter of which ranked second in the city in terms of aortic surgeries performed in 2020.
The company is looking to branch out into other surgical specialties and will use the funding to expand its network.
David Hoidal, DeltaHealth’s chief executive, said: “Swire has long term committed capital similar to Eight Roads and they value the importance of quality, operational excellence, commitment to service, brand and reputation – all of which are the core pillars we have at DeltaHealth.
“As Swire expands its healthcare portfolio, I believe it can lead to potential synergies with DeltaHealth. Its solid background in property development will also be of great value to us as we build out phase two in the future.”
